Connor Clark & Lunn Investment Management Ltd. Purchases Shares of 69,028 Axon Enterprise, Inc. (NASDAQ:AXON)

Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 69,028 shares of the biotechnology company’s stock, valued at approximately $41,025,000.

Other institutional investors have also added to or reduced their stakes in the company. Public Sector Pension Investment Board boosted its position in Axon Enterprise by 19.2% during the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after buying an additional 500 shares during the period. CIBC Asset Management Inc boosted its position in Axon Enterprise by 9.2% during the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after buying an additional 895 shares during the period. Axxcess Wealth Management LLC purchased a new stake in Axon Enterprise during the third quarter valued at about $814,000. Soros Capital Management LLC bought a new position in shares of Axon Enterprise during the third quarter valued at about $630,000. Finally, Friedenthal Financial raised its stake in shares of Axon Enterprise by 961.7% during the fourth quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock valued at $808,000 after acquiring an additional 1,231 shares during the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, President Joshua Isner sold 1,291 shares of the company’s stock in a transaction dated Tuesday, December 17th. The stock was sold at an average price of $642.43, for a total transaction of $829,377.13. Following the completion of the sale, the president now owns 181,892 shares in the company, valued at approximately $116,852,877.56. This trade represents a 0.70 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 5,146 shares of company stock worth $3,262,847. 6.10% of the stock is currently owned by company insiders.

Axon Enterprise Price Performance

Shares of AXON opened at $557.89 on Thursday. The stock has a market cap of $42.75 billion, a PE ratio of 144.16, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99. The firm’s 50-day simple moving average is $595.56 and its two-hundred day simple moving average is $532.90.

Analysts Set New Price Targets

Several brokerages have recently commented on AXON. The Goldman Sachs Group upped their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. Needham & Company LLC reaffirmed a “buy” rating and set a $600.00 price objective on shares of Axon Enterprise in a research note on Wednesday, February 26th. Barclays reaffirmed a “hold” rating on shares of Axon Enterprise in a research note on Monday. Craig Hallum downgraded shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday. Finally, Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $587.38.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.